Else Nutrition Holdings (TSXV:BABY) is Rich’s Newest Pick

Else Nutrition

Rich returns with another company profile. This time he’s moving outside the cannabis space to highlight an exciting company that’s straddling two huge markets. That company is Else Nutrition Holdings Inc. (TSXV:BABY) (OTCPK:BABYF).

Else Nutrition is a food and nutrition company focusing on researching, developing, manufacturing, marketing, selling, and/or licensing plant-based food and nutrition products. The products are targeted for the infant, toddler, children, and adult markets.

“I think that this company has a great future and huge potential,” says Rich. “I absolutely love this company.”

What Makes Else Nutrition Unique?

What sets Else Nutrition apart from competitors is its 100% plant-based, non-soy alternative to dairy-based baby formula.

This formula is the first of its kind on the market. Made from almonds and buckwheat, it’s free of GMOs, pesticides, hormones, antibiotics, gluten, and phytoestrogens. This means it is a healthier and more natural option for toddlers (12–36 months) as a real alternative to dairy-based baby formulas.

Enter Your E-mail Address To Subscribe

* indicates required

Because it doesn’t use dairy or soy, Else Nutrition’s formula is the best solution for babies who are lactose intolerant and/or have other sensitivities that keep them from experiencing the benefit of existing products.

“This company could change the world, and that’s why I wanted to bring it to you first,” Rich explains.

The reason Else’s formula is such a novel innovation in the industry is that, right now, the vast majority of infant formulas are milk-based. Yet cow’s milk is the number one allergen for children aged five or younger. Milk allergies currently affect half of food-allergic children in America who are less than one year old.

As for the other non-dairy alternatives, nearly all of them are soy-based. But approximately 40% percent of children allergic to cow’s milk are also allergic to soy milk.

What this means is that there are entire segments of the population that can’t drink either cow’s milk nor any of the alternatives except for Else Nutrition’s 100% plant-based formula. This kind of exclusive market reach is unprecedented, especially in a market as important as children’s health and nutrition.

“If you’re a parent and you want your kids to be healthy, you need to move away from milk,” says Rich. “You need to get into plant-based nutrition.”

Else Nutrition’s Two Huge Markets

According to a report from Hexa Research, the global market for infant formula is expected to exceed $90 billion USD by 2025 with a CAGR of 9.35%. This growth is being driven largely by the introduction of milk formulas with additional nutrition, such as the Else Nutrition 100% plant-based formula.

The other market that Else is ready to disrupt is the plant-based foods market. Companies like Beyond Meat (NASDAQ:BYND) have been doing exceptionally well this year, but have yet to target children’s food or infant formulas.

Data from the Plant Based Foods Association and The Good Food Institute reveals that sales of plant-based foods have grown 11 percent across America in the past year. The US market for 2019 is valued at $4.5 billion and is likely to continue to grow at a similar rate.

Else Nutrition debuted on the TSX Venture Exchange in June at $0.69 and has since fallen to $0.33. The company plans to begin releasing its products in the US beginning next spring.

“In my opinion this stock is near a 52-week low and this is the time to buy,” says Rich.

What do you think? Is Else Nutrition an important stock to watch in the coming months? If you liked this video, be sure to check out Rich’s other company profiles of Green Growth Brands (CSE:GGB) (OTCQB:GGBXF) and Victory Square Technologies (CSE:VST) (OTCQX:VSQTF).

Featured image: DepositPhotos © Ipatov

Please See Disclaimer

If You Liked This Article Click To Share


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, Else Nutrition Holdings Inc. Bitrics Markets Group Inc. and/or Iman Consulting Group has or expects to receive $800 Canadian dollars from Market Jar Media Inc. for the creation and distribution of the video.

3) Statements and opinions expressed are the opinions of the author and not Bitrics Markets Group Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Bitrics Markets Group Inc. for this Article. Bitrics Markets Group Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Bitrics Markets Group Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Bitrics Markets Group Inc. relies upon the authors to accurately provide this information and Bitrics Markets Group Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Bitrics Markets Group Inc.’s terms of use and full legal disclaimer as set forth here.. This Article is not a solicitation for investment. Bitrics Markets Group Inc. does not render general or specific investment advice and the information on richtvlive.com should not be considered a recommendation to buy or sell any security. Bitrics Markets Group Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

5) Bitrics Markets Group Inc. and its owners, members, officers, directors, partners and consultants may own shares of the profiled companies, which it may sell at any time, including as soon as it deposits such shares into its trading accounts, during our campaign of the profiled companies stock, after our campaign or at any other time. We also may buy and sell securities in the profiled companies which may cause (a) decline in the price of the profiled companies stock due to our selling activities, (b) increased volatility due to our buying and selling of the profiled companies stock and (c) permit us to make substantial profits while we are profiling each of these companies, yet may result in a diminished value to the stock for investors. for any company mentioned in the Article.